摘要
2019年年底,武汉市陆续发现了多例新型冠状病毒感染的肺炎(简称新冠肺炎)患者,并迅速蔓延到我国其他地区及境外。本文对我国国家卫生健康委员会颁布的《新型冠状病毒肺炎诊疗方案(试行第七版)》进行延伸解读,聚焦血液透析患者与新冠肺炎诊疗的相关问题。
At the end of 2019,many cases of pneumonia caused by a 2019-nCoV were identified,and spread aggressively to entire China and other countries.In this article,we gave an extended interpretation on Chinese Clinical Guidance for COVID-19 Diagnosis and Treatment(7 th edition,trial implementation)issued by National Health Committee of the People's Republic of China,focusing on hemodialysis patients and related issues of COVID-19.
作者
周莉
钟慧
付平
ZHOU Li;ZHONG Hui;FU Ping(Department of Nephrology,West China Hospital,Sichuan University,Chengdu 610041,China)
出处
《临床肾脏病杂志》
2020年第4期322-326,共5页
Journal Of Clinical Nephrology
基金
四川大学华西医院学科卓越发展1·3·5工程临床研究孵化项目(2019HXFH043)。
关键词
新型冠状病毒肺炎
诊疗
终末期肾病
血液透析
Corona virus disease 2019
Diagnosis and treatment
End stage renal disease
Hemodialysis
